World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 16 December 2017
Main ID:  NCT03044561
Date of registration: 02/02/2017
Prospective Registration: No
Primary sponsor: Ain Shams University
Public title: Sildenafil Citrate of in Vitro Fertilization After Multiple IVF Failures Attributed to Poor Endometrial Development
Scientific title: Effect of Sildenafil Citrate on the Outcome of in Vitro Fertilization After Multiple IVF Failures Attributed to Poor Endometrial Development
Date of first enrolment: January 31, 2017
Target sample size: 80
Recruitment status: Recruiting
URL:  https://clinicaltrials.gov/show/NCT03044561
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).  
Phase:  Phase 4
Countries of recruitment
Egypt
Contacts
Name:     amr elsayed
Address: 
Telephone: 01090808047
Email:
Affiliation: 
Name:     ahmed khairy, professor
Address: 
Telephone: 01090808047
Email:
Affiliation: 
Name:     ahmed khairy, professor
Address: 
Telephone:
Email:
Affiliation:  Ain Shams University
Key inclusion & exclusion criteria

Inclusion Criteria:

- (1) cases of infertility, older than 20 years of age and not older than 40 years.

- (2) Body mass index (BMI):20-29.

- (3) women have experienced two or more implantation failure attributed to inadequate
endometrial development.

Exclusion Criteria:

- (1) Uterine abnormalities (e.g. septate, bicornuate and fibroid uterus, Asherman
Syndrome).

- (2) Any contraindication to sildenafil citrate or any of the components of its
formulation including:

- Concurrent use of organic nitrites and nitrates.

- Severe hepatic impairment.

- Severe renal impairment.

- Hypotension.

- Recent stroke or heart attack.



Age minimum: 20 Years
Age maximum: 40 Years
Gender: Female
Health Condition(s) or Problem(s) studied
IVF Failure
Intervention(s)
Drug: Sildenafil Citrate
Drug: matching placebo
Primary Outcome(s)
endometrial thickness measures [Time Frame: 21 days]
Secondary Outcome(s)
Secondary ID(s)
amr el-sayed 2017
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history